Literature DB >> 24671250

[Prostate and bladder cancer: detection of disseminated tumor cells in bone marrow].

R Nawroth1, D Weckermann, M Retz.   

Abstract

The prognosis of prostate and bladder cancer patients is predominantly determined by the detection of distant sites of metastasis. In clinical routine, virtually only lymph node staging is of relevance to determine metastasis. Detection and characterization of disseminated tumor cells in peripheral blood or bone marrow is an additional parameter of prognostic significance. In this article, we will summarize recent progress on the prognostic value of disseminated tumor cells in bone marrow and its translation into routine clinical analysis.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24671250     DOI： 10.1007/s00120-014-3445-0

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  19 in total

1.  Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors.

Authors:  Yusuke Shiozawa; Kenneth J Pienta; Russell S Taichman
Journal:  Clin Cancer Res       Date:  2011-06-15       Impact factor: 12.531

Review 2.  The prostate cancer bone marrow niche: more than just 'fertile soil'.

Authors:  Elisabeth A Pedersen; Yusuke Shiozawa; Kenneth J Pienta; Russell S Taichman
Journal:  Asian J Androl       Date:  2012-02-27       Impact factor: 3.285

3.  Disseminated prostate cancer cells can instruct hematopoietic stem and progenitor cells to regulate bone phenotype.

Authors:  Jeena Joseph; Yusuke Shiozawa; Younghun Jung; Jin Koo Kim; Elisabeth Pedersen; Anjali Mishra; Janet Linn Zalucha; Jingcheng Wang; Evan T Keller; Kenneth J Pienta; Russell S Taichman
Journal:  Mol Cancer Res       Date:  2012-01-12       Impact factor: 5.852

4.  Utility of urothelial mRNA markers in blood for staging and monitoring bladder cancer.

Authors:  Mercedes Marín-Aguilera; Lourdes Mengual; María José Ribal; Elisabet Ars; José Ríos; Cristina Gázquez; Humberto Villavicencio; Antonio Alcaraz
Journal:  Urology       Date:  2011-11-04       Impact factor: 2.649

5.  Cytokeratin-20 reverse-transcriptase polymerase chain reaction as a new tool for the detection of circulating tumor cells in peripheral blood and bone marrow of bladder cancer patients.

Authors:  M Retz; J Lehmann; C Röder; K Weichert-Jacobsen; T Loch; E Romahn; C Lühl; H Kalthoff; M Stöckle
Journal:  Eur Urol       Date:  2001-05       Impact factor: 20.096

6.  Long-term follow-up of bladder cancer patients with disseminated tumour cells in bone marrow.

Authors:  Margitta Retz; Jens Rotering; Roman Nawroth; Alexander Buchner; Michael Stöckle; Juergen E Gschwend; Jan Lehmann
Journal:  Eur Urol       Date:  2010-12-22       Impact factor: 20.096

7.  Natural history of progression after PSA elevation following radical prostatectomy.

Authors:  C R Pound; A W Partin; M A Eisenberger; D W Chan; J D Pearson; P C Walsh
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

8.  A pooled analysis of bone marrow micrometastasis in breast cancer.

Authors:  Stephan Braun; Florian D Vogl; Bjørn Naume; Wolfgang Janni; Michael P Osborne; R Charles Coombes; Günter Schlimok; Ingo J Diel; Bernd Gerber; Gerhard Gebauer; Jean-Yves Pierga; Christian Marth; Daniel Oruzio; Gro Wiedswang; Erich-Franz Solomayer; Günther Kundt; Barbara Strobl; Tanja Fehm; George Y C Wong; Judith Bliss; Anne Vincent-Salomon; Klaus Pantel
Journal:  N Engl J Med       Date:  2005-08-25       Impact factor: 91.245

Review 9.  Prostate cancer and parasitism of the bone hematopoietic stem cell niche.

Authors:  Chunyan Yu; Yusuke Shiozawa; Russell S Taichman; Laurie K McCauley; Kenneth Pienta; Evan Keller
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2012       Impact factor: 1.807

10.  Increased expression of putative cancer stem cell markers in the bone marrow of prostate cancer patients is associated with bone metastasis progression.

Authors:  Estelle Ricci; Eve Mattei; Charles Dumontet; Colby L Eaton; Freddy Hamdy; Gabri van der Pluije; Marco Cecchini; George Thalmann; Philippe Clezardin; Marc Colombel
Journal:  Prostate       Date:  2013-09-21       Impact factor: 4.104
View more
  2 in total

1.  [Detection of lymphovascular invasion in urothelial carcinoma of the bladder through D2-40 immunostaining].

Authors:  T Martini; P Ströbel; A Steidler; N Petrakopoulou; P Erben; C Bolenz
Journal:  Urologe A       Date:  2015-01       Impact factor: 0.639

Review 2.  Advancing Cancer Research and Medicine with Single-Cell Genomics.

Authors:  Bora Lim; Yiyun Lin; Nicholas Navin
Journal:  Cancer Cell       Date:  2020-04-13       Impact factor: 31.743
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.